{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:20:29Z","timestamp":1772130029372,"version":"3.50.1"},"reference-count":63,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1UG1CA189824"],"award-info":[{"award-number":["1UG1CA189824"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2UG1CA189854"],"award-info":[{"award-number":["2UG1CA189854"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["2 U54 GM104940-02"],"award-info":[{"award-number":["2 U54 GM104940-02"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>The purpose of this pilot study was to assess Chronic Myeloid Leukemia (CML) patients\u2019 adherence to, beliefs about, and barriers to oral anticancer agents (OAC) using brief self-report measures in community-based cancer clinics. Patients completed a structured interview including a health literacy assessment, a Brief Medication Questionnaire, two single-item self-report adherence questions, and the Medications Adherence Reasons Scale. Of the 86 participants, 88.4% were white; 55.8% male; mean age, 58.7 years; and 22.1% had limited health literacy. Nonadherence (missing at least one dose in the last week) was reported by 18.6% of participants and associated (p &lt; 0.003) with less-than-excellent perceived ability to take CML medications (16.3%). Black participants reported more difficulty taking CML medications than white participants (28.6% vs. 8.3%, p = 0.053). Among all participants, 43.0% reported their CML medicine was ineffective and 24.4% that taking CML pills was somewhat to very hard. The most common reasons for missing a dose were simply missed it (24.4%) and side effects (18.6%). Most patients perceived their ability to take CML medication was good to excellent, yet nearly one in five reported missing at least one dose in the last week. Brief, no-cost self-report assessments to screen CML patients\u2019 OAC adherence, barriers, and beliefs could facilitate counseling in busy community cancer clinics.<\/jats:p>","DOI":"10.3390\/ijerph182111045","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:22:02Z","timestamp":1634862122000},"page":"11045","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Assessment of Oral Chemotherapy Nonadherence in Chronic Myeloid Leukemia Patients Using Brief Measures in Community Cancer Clinics: A Pilot Study"],"prefix":"10.3390","volume":"18","author":[{"given":"Terry C.","family":"Davis","sequence":"first","affiliation":[{"name":"Department of Medicine, Louisiana State University Health\u2014Shreveport, Shreveport, LA 71130, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie L.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Medicine, Louisiana State University Health\u2014Shreveport, Shreveport, LA 71130, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Mills","sequence":"additional","affiliation":[{"name":"Department of Medicine, Louisiana State University Health\u2014Shreveport, Shreveport, LA 71130, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn J.","family":"Lesser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Mark","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Schulz","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9006-4064","authenticated-orcid":false,"given":"Kathryn E.","family":"Weaver","sequence":"additional","affiliation":[{"name":"Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamala A.","family":"Pawloski","sequence":"additional","affiliation":[{"name":"Metro-Minnesota Community Oncology Research Consortium, St. Louis Park, MN 55416, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ctrv.2012.12.014","article-title":"Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review","volume":"39","author":"Verbrugghe","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"ref_2","first-page":"16","article-title":"Oral chemotherapy: Not just an ordinary pill","volume":"11","author":"Thompson","year":"2016","journal-title":"Am. Nurse Today"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2008.2003","article-title":"NCCN task force report: Oral chemotherapy","volume":"6","author":"Weingart","year":"2008","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_4","first-page":"5401","article-title":"Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: The ADAGIO study","volume":"113","author":"Noens","year":"2009","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00019053-200725060-00004","article-title":"Treatment interruptions and non-adherence with imatinib and associated healthcare costs: A retrospective analysis among managed care patients with chronic myelogenous leukaemia","volume":"25","author":"Darkow","year":"2007","journal-title":"PharmacoEconomics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/j.2055-2335.2006.tb00584.x","article-title":"Factors influencing adherence to molecular therapies in haematology-oncology outpatients","volume":"36","author":"Larizza","year":"2006","journal-title":"J. Pharm. Pract. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/phar.1399","article-title":"Improving adherence to oral cancer therapy in clinical practice","volume":"34","author":"McCue","year":"2014","journal-title":"Pharmacotherapy"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.canep.2014.03.012","article-title":"Adherence influencing factors in patients taking oral anticancer agents: A systematic review","volume":"38","author":"Mathes","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"ref_9","first-page":"99","article-title":"Challenges of oral chemotherapy","volume":"3","author":"Schellens","year":"2005","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"ref_10","unstructured":"Sabate, E. (2003). Adherence to Long-Term Therapies: Evidence for Action, World Health Organization. Available online: https:\/\/www.who.int\/chp\/knowledge\/publications\/adherence_full_report.pdf."},{"key":"ref_11","first-page":"2669","article-title":"Oral cancer chemotherapy: The promise and the pitfalls","volume":"5","author":"McLeod","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"217047","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: An overview","volume":"2015","author":"Lam","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clml.2012.04.002","article-title":"Adherence to BCR-ABL inhibitors: Issues for CML therapy","volume":"12","author":"Jabbour","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_15","unstructured":"National Cancer Institute Cancer Stat Facts: Leukemia\u2014Chronic Myeloid Leukemia (CML) (2021, January 01). Surveillance, Epidemiology, and End Results Program, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/cmyl.html."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2009.26.3087","article-title":"Adherence in the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib","volume":"28","author":"Marin","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2012.082511","article-title":"Measurement of adherence of BCR- ABL inhibitor therapy in chronic myeloid leukemia: Current situation and future challenges","volume":"99","author":"Noens","year":"2014","journal-title":"Hematologica"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2010-10-309807","article-title":"Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy","volume":"117","author":"Ibrahim","year":"2011","journal-title":"Blood"},{"key":"ref_19","first-page":"168","article-title":"Medication adherence among patients with chronic myeloid leukemia: The impact of financial burden and psychosocial distress","volume":"8","author":"Buzaglo","year":"2017","journal-title":"J. Oncol. Navig. Surviv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1182\/asheducation-2013.1.176","article-title":"Update on current monitoring recommendation in chronic myeloid leukemia: Practical points for clinical practice","volume":"2013","author":"Oehler","year":"2013","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.critrevonc.2015.08.025","article-title":"To adhere or not to adhere: Rates and reasons of medication adherence in hematological cancer patients","volume":"97","author":"Hall","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/hon.2005","article-title":"Imatinib plasma trough levels in chronic myeloid leukaemia: Results of a multicentre study CSTI571AIL11TGLIVEC","volume":"30","author":"Volchek","year":"2012","journal-title":"Hematol Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000345722","article-title":"Adherence to tyrosine kinase inhibitor therapy for chronic myeloid leukemia: A Brazilian single-center cohort","volume":"130","author":"Pagnano","year":"2013","journal-title":"Acta Haematol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1182\/blood.V116.21.1514.1514","article-title":"A Global retrospective and physician-based analysis of adherence to tyrosine kinase inhibitor (TKI) therapies for chronic myeloid leukemia (CML)","volume":"116","author":"Guilhot","year":"2010","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/phar.1174","article-title":"Preliminary validation of self-assessment tool to measure imatinib adherence in patients with chronic myeloid leukemia","volume":"33","author":"Daouphars","year":"2013","journal-title":"Pharmacotherapy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1177\/1078155218800384","article-title":"Adherence to oral chemotherapy: Challenges and opportunities","volume":"25","author":"Krikorian","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/1078155218759184","article-title":"Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukemia","volume":"25","author":"Santoleri","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1200\/JOP.2016.019729","article-title":"Treatment satisfaction and adherence to oral chemotherapy in patients with cancer","volume":"13","author":"Jacobs","year":"2017","journal-title":"J. Oncol. Pract."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Timmers, L., Boons, C., Verbrugghe, M., van den Bemt, B., Van Hecke, A., and Hugtenburg, J. (2017). Supporting adherence to oral anticancer agents: Clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3110-2"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00432-017-2372-z","article-title":"Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries","volume":"143","author":"Geissler","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.24926\/iip.v5i3.347","article-title":"Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8)","volume":"5","author":"Tan","year":"2014","journal-title":"Innov. Pharm."},{"key":"ref_32","unstructured":"Kutner, M., Greenberg, E., Jin, Y., and Paulsen, C. (2006). The Health Literacy of America\u2019s Adults: Results From the 2003 National Assessment of Adult Literacy."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/jocn.12471","article-title":"A single-item self-report medication adherence question predicts hospitalisation and death in patients with heart failure","volume":"23","author":"Wu","year":"2014","journal-title":"J. Clin. Nurs."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sapharm.2009.06.005","article-title":"Development of a new scale to measure self-reported medication nonadherence","volume":"11","author":"Unni","year":"2015","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2147\/PPA.S205359","article-title":"Using the Medication Adherence Reasons Scale (MAR-Scale) to identify the reasons for nonadherence across multiple disease conditions","volume":"13","author":"Unni","year":"2019","journal-title":"Patient Prefer. Adherence"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0738-3991(98)00107-4","article-title":"The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence","volume":"37","author":"Svarstad","year":"1999","journal-title":"Patient Educ. Couns."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10461-012-0326-7","article-title":"Evaluation of the Single-Item Self-Rating Adherence Scale for use in routine clinical care of people living with HIV","volume":"17","author":"Feldman","year":"2013","journal-title":"AIDS Behav."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10461-007-9261-4","article-title":"Optimal recall period and response task for self-reported HIV medication adherence","volume":"12","author":"Lu","year":"2008","journal-title":"AIDS Behav."},{"key":"ref_39","unstructured":"(2021, January 01). Medical Event Monitoring System (MEMS). Available online: https:\/\/www.westrock.com\/en\/products\/folding-cartons\/memscap."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/MLR.0b013e3180616c1b","article-title":"Development and validation of a short-form, rapid estimate of adult literacy in medicine","volume":"45","author":"Arozullah","year":"2007","journal-title":"Med. Care"},{"key":"ref_41","unstructured":"(2021, January 01). SAS Institute SAS Analytics Software and Solutions (Computer Software). Available online: https:\/\/www.sas.com\/en_us\/software\/all-products.html."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.leukres.2013.07.003","article-title":"Profiling chronic myeloid leukemia patients reporting intentional and unintentional non-adherence to lifelong therapy with tyrosine kinase inhibitors","volume":"38","author":"Efficace","year":"2014","journal-title":"Leuk. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1078155213520261","article-title":"Medication adherence among adults prescribed imatinib, dasatinib, or nilontinib for treatment of chronic myeloid leukemia","volume":"21","author":"Anderson","year":"2015","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/bjc.2012.349","article-title":"Why are patients with chronic myeloid leukemia (non) adherent?","volume":"107","author":"Abraham","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Talens, A., Guilabert, M., Lumbreras, B., Aznar, M., and L\u00f3pez-Pintor, E. (2021). Medication experience and adherence to oral chemotherapy: A qualitative study of patients\u2019 and health professionals\u2019 perspectives. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18084266"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JOP.2015.004572","article-title":"Oral anticancer medication adherence, toxicity reporting, and counseling: A study comparing health care providers and patients","volume":"11","author":"Gandhi","year":"2015","journal-title":"J. Oncol. Pract."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archinternmed.2011.39","article-title":"Helping patients simplify and safely use complex prescription regimens","volume":"171","author":"Wolf","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pec.2010.06.029","article-title":"Measuring patients\u2019 self-efficacy in understanding and using prescription medication","volume":"80","author":"Cameron","year":"2010","journal-title":"Patient Educ. Couns."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1179\/cih.2009.2.3.294","article-title":"Medication label improvement: An issue at the intersection of health literacy and patient safety","volume":"2","author":"Bailey","year":"2009","journal-title":"J. Commun. Healthc."},{"key":"ref_50","first-page":"715","article-title":"Predictors of misunderstanding pediatric liquid medication instructions","volume":"41","author":"Bailey","year":"2009","journal-title":"Fam. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11606-008-0833-4","article-title":"Improving patient understanding of prescription drug label instructions","volume":"24","author":"Davis","year":"2009","journal-title":"J. Gen. Intern. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s11606-008-0662-5","article-title":"Literacy, social stigma, and HIV medication adherence","volume":"23","author":"Waite","year":"2008","journal-title":"J. Gen. Intern. Med."},{"key":"ref_53","first-page":"1000292","article-title":"Barriers and facilitators to colorectal cancer screening among rural women in community clinics by heath literacy","volume":"6","author":"Davis","year":"2017","journal-title":"J. Women\u2019s Health Issues Care"},{"key":"ref_54","first-page":"497","article-title":"Changes in colorectal cancer screening knowledge, behavior, beliefs, self-efficacy, and barriers among community health clinic patients after a health literacy intervention","volume":"7","author":"Arnold","year":"2017","journal-title":"J. Community Med. Health Educ."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5993\/AJHB.40.3.2","article-title":"3rd annual fecal occult blood testing in community health clinics","volume":"40","author":"Arnold","year":"2016","journal-title":"Am. J. Health Behav."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/jwh.2014.4967","article-title":"Sustaining mammography screening among the medically underserved: A follow-up evaluation","volume":"24","author":"Davis","year":"2015","journal-title":"J. Women\u2019s Health"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s11606-013-2743-3","article-title":"Improving mammography screening among the medically underserved","volume":"29","author":"Davis","year":"2014","journal-title":"J. Gen. Intern. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1055-9965.EPI-13-0795","article-title":"Strategies to improve repeat fecal occult blood testing cancer screening","volume":"23","author":"Davis","year":"2014","journal-title":"Cancer Epidemiol. Prev. Biomarkers"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1002\/cncr.28272","article-title":"Improving colorectal cancer screening in community clinics","volume":"119","author":"Davis","year":"2013","journal-title":"Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/10810730.2012.713441","article-title":"Literacy barriers to colorectal cancer screening in community clinics","volume":"17","author":"Arnold","year":"2012","journal-title":"J. Health Commun."},{"key":"ref_61","unstructured":"(2021, January 01). National Institute of Health Clear Communication: Health Literacy, Available online: https:\/\/www.nih.gov\/institutes-nih\/nih-office-director\/office-communications-public-liaison\/clear-communication\/health-literacy."},{"key":"ref_62","unstructured":"(2021, January 01). U.S. Department of Health and Human Services National Action Plan to Improve Health Literacy, Available online: https:\/\/health.gov\/our-work\/national-health-initiatives\/health-literacy\/national-action-plan-improve-health-literacy."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/10810730500228631","article-title":"A qualitative study of literacy and patient response to HIV medication adherence questionnaires","volume":"10","author":"Wolf","year":"2005","journal-title":"J. Health Commun."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/21\/11045\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:19:47Z","timestamp":1760167187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/21\/11045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":63,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijerph182111045"],"URL":"https:\/\/doi.org\/10.3390\/ijerph182111045","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]}}}